This is further supported by the observed upregulation of the muscle contraction signaling pathway, through which skeletal muscle activity activates the AMPK/PGC-1α axis, promoting mitochondrial biogenesis, increasing fatty acid oxidation, and mitigating obesity-associated metabolic dysfunction (44). The gene discussed is PPARGC1A; the disease is obesity disorder.